Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D is important for skin health and can help treat psoriasis, atopic dermatitis, and vitiligo.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Cinnamon bark extract may help prevent weight loss and hair loss in breast cancer patients during chemotherapy and is safe to use.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

PLD is an effective and safer alternative for treating breast cancer.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document concludes that hair loss is influenced by genetics and other factors, and while treatments like finasteride can help, they have limitations and side effects.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Hair loss is a common side effect of hormone treatments for cancer.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.